Efforts to develop a vaccine against the strain of Ebola driving the deadly outbreak in Democratic Republic of Congo are expanding, with an experimental shot developed by an Egypt-based pharmaceutical company set to advance toward human testing.
Efforts to develop a vaccine against the strain of Ebola driving the deadly outbreak in Democratic Republic of Congo are expanding, with an experimental shot developed by an Egypt-based pharmaceutical company set to advance toward human testing.
<iframe src="https://statesidedaily.com/embed/cluster/3ead392883e78f6c2d8481ad188d0cfb485132aa" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Ebola Vaccine Race Expands as Congo Bundibugyo Outbreak Grows"></iframe>